CUSIP: 163572209
Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
5,904,570
-
Share change
-
+1,482,567
-
Total reported value
-
$47,236,000
-
Price per share
-
$8.00
-
Number of holders
-
26
-
Value change
-
+$11,860,661
-
Number of buys
-
14
-
Number of sells
-
7
Quarterly Holders Quick Answers
What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2018
-
Previous quarter:
Q4 2017
Recent filing periods for CUSIP 163572209:
Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q1 2018
As of 31 Mar 2018,
CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,904,570 shares.
The largest 10 holders included
ACUTA CAPITAL PARTNERS, LLC, WELLINGTON MANAGEMENT GROUP LLP, ARS Investment Partners, LLC, Cortina Asset Management, LLC, VANGUARD GROUP INC, ROYCE & ASSOCIATES LP, GAGNON SECURITIES LLC, WELLS FARGO & COMPANY/MN, Gagnon Advisors, LLC, and Benchmark Capital Advisors.
This page lists
26
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.